CliffBio
small molecule

NICODERM CQ

NICOTINE

Loss of exclusivity—loss of exclusivity
CompanyCHATTEM INC DBA SANOFI CONSUMER HEALTHCARE

Drug detail

Brand nameNICODERM CQ
Active ingredientNICOTINE
Strength21MG/24HR
Dosage formFILM, EXTENDED RELEASE
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalAugust 1996
Marketing statusOTC

More from CHATTEM INC DBA SANOFI CONSUMER HEALTHCARE

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

NICODERM CQ patent cliff — loss of exclusivity — | CliffBio